Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 9.55
+0.13 (1.38%)
At close: Oct 23, 2026
| Market Cap | 3.74B -29.6% |
| Revenue (ttm) | 710.55M +3.2% |
| Net Income | 103.98M -25.8% |
| EPS | 0.27 -25.7% |
| Shares Out | 392.08M |
| PE Ratio | 35.92 |
| Forward PE | n/a |
| Dividend | 0.20 (2.09%) |
| Ex-Dividend Date | Apr 30, 2026 |
| Volume | 3,453,153 |
| Open | 9.33 |
| Previous Close | 9.42 |
| Day's Range | 9.06 - 9.58 |
| 52-Week Range | 8.45 - 13.84 |
| Beta | 0.18 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |